DARPin_9-29-Targeted Mini Gold Nanorods Specifically Eliminate HER2-Overexpressing Cancer Cells

Galina Proshkina, Sergey Deyev, Anastasiya Ryabova, Francesco Tavanti, Maria Cristina Menziani, Roy Cohen, Liat Katrivas, Alexander Kotlyar

Результат исследований: Материалы для журналаСтатьярецензирование

5 Цитирования (Scopus)


We have demonstrated that designed ankyrin repeat protein (DARPin)_9-29, which specifically targets human epidermal growth factor receptor 2 (HER2), binds tightly to gold mini nanorods (GNRs). Molecular dynamic simulations showed that a single layer of DARPin_9-29 molecules is formed on the surface of the nanorod and that conjugation with the nanorod does not involve the protein's domain responsible for specific binding to HER2. The nanorod-DARPin (DARPin-GNR) conjugate is specifically bound (in nanomolar concentrations) to human breast adenocarcinoma SK-BR-3 cells overexpressing HER2. Illumination by near-infrared light (850 nm) led to almost complete eradication of the conjugate-treated SK-BR-3 cells; the viability of epithelial human breast cancer cells expressing normal amounts of the receptor was much less affected by the illumination. The results reported here pave the way toward application of DARPin-GNR conjugates in phototherapy of cancer.

Язык оригиналаАнглийский
Страницы (с-по)34645-34651
Число страниц7
ЖурналACS Applied Materials and Interfaces
Номер выпуска38
СостояниеОпубликовано - 25 сен 2019
Опубликовано для внешнего пользованияДа

ASJC Scopus subject areas

  • Materials Science(all)

Fingerprint Подробные сведения о темах исследования «DARPin_9-29-Targeted Mini Gold Nanorods Specifically Eliminate HER2-Overexpressing Cancer Cells». Вместе они формируют уникальный семантический отпечаток (fingerprint).